Friday, April 26, 2024 4/26/2024

Symptom Care at Home-Heart Failure: Developing and piloting a symptom monitoring and self-management coaching system for patients with heart failure

Award Number: K23HL148545
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

This is a K23 award application for Dr. Youjeong Kang, an experienced clinician in inpatient and home health care settings, to independently develop and test innovative interventions for heart failure (HF) management that are effective and scalable, as well as improve care for HF patients. The K23 will provide her the support necessary to acquire critical skills in four key career development areas: 1) enhance expertise in HF symptoms and self-management based on patient-reported outcomes (PRO) data; 2) develop expertise in clinical trial design and implementation for the home-based symptom management intervention testing; 3) acquire further professional development and leadership skills; and 4) obtain skills in developing and adapting technology-aided interventions (i.e., app-based platform). To achieve her goals, Dr. Kang has assembled an interdisciplinary mentoring team comprised of Drs. Kathi Mooney (Primary Mentor), an internationally recognized expert in oncology symptom management using telephone-enabled interventions; Josef Stehlik (Co-Mentor), an experienced cardiologist with an independent research career focused on HF treatments; and Gary Donaldson (Advisor), an expert in multivariate longitudinal statistical analyses. Keeping HF patients at home with a low symptom burden after hospital discharge is challenging. Evidence shows that delay in HF symptom recognition and poor self-management are associated with unplanned emergency department visits and rehospitalizations. Clinical trials aimed at preventing rehospitalization using telemonitoring have shown limited utility suggesting that monitoring physical changes alone may not be sufficient to maintain stability of HF patients at home. A recent cancer study has demonstrated that patients receiving cancer chemotherapy achieved a 40% reduction in symptoms using Symptom Care at Home (SCH), a computer-interface telephonic interactive voice response system pairing patient-reported symptoms with automated real-time, self-management coaching. While a few HF studies have used interventions that monitored symptoms, no studies have tested a system that monitors and provides real-time, self-management coaching tailored to specific PRO. Dr. Kang’s objective is to pilot an adaption of the SCH system to HF resulting in preliminary data to support a fully-powered randomized control trial to test an adapted SCH-HF system that could be widely disseminated. She proposes the following Specific Aims over two-parts: Aim 1] Tailor the real-time self-management coaching system to integrate HF symptom monitoring and self- management coaching into the SCH-HF system; and Aim 2] Conduct a pilot randomized controlled trial (RCT) to assess the feasibility, acceptability, and preliminary efficacy of the SCH-HF system. The proposed research is significant because it expands our understanding into HF symptom monitoring and management using PRO in the home setting. The proposal is innovative because it integrates HF clinician and patient perspectives to develop a daily home monitoring and real-time self-management coaching system.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $198,245 )
2023	2023	UNIVERSITY OF UTAH	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Cardiovascular Diseases Research	001	4	3/2/2023	NON-COMPETING CONTINUATION	$145,451
2023	2023	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Cardiovascular Diseases Research	000	3	3/1/2023	SUPPLEMENT FOR EXPANSION	$52,794
														Subtotal = $198,245

Issue Date FY: 2022 ( Subtotal = $145,324 )
2022	2022	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Cardiovascular Diseases Research	000	3	4/6/2022	NON-COMPETING CONTINUATION	$145,324
														Subtotal = $145,324

Issue Date FY: 2021 ( Subtotal = $145,287 )
2021	2021	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Cardiovascular Diseases Research	001	2	4/30/2021	NON-COMPETING CONTINUATION	$145,287
2021	2020	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Cardiovascular Diseases Research	000	1	11/20/2020	NEW	$0
														Subtotal = $145,287

Issue Date FY: 2020 ( Subtotal = $145,337 )
2020	2020	UNIVERSITY OF UTAH, THE	201 PRESIDENTS CIR	SALT LAKE CITY	UT	84112	SALT LAKE	USA	Cardiovascular Diseases Research	000	1	4/10/2020	NEW	$145,337
														Subtotal = $145,337

Grand Total All Awards = $634,193

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Symptom Care at Home-Heart Failure: Developing and piloting a symptom monitoring and self-management coaching system for patients with heart failure

Award Number: K23HL148545

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer